Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$316M |
| 2 |
Alibaba
BABA
|
+$185M |
| 3 |
Verizon
VZ
|
+$135M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$131M |
| 5 |
McKesson
MCK
|
+$126M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$449M |
| 2 |
Gilead Sciences
GILD
|
+$297M |
| 3 |
Meta Platforms (Facebook)
META
|
+$218M |
| 4 |
Intel
INTC
|
+$215M |
| 5 |
Coca-Cola
KO
|
+$198M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.5% |
| 2 | Technology | 12.69% |
| 3 | Industrials | 10.47% |
| 4 | Financials | 10.17% |
| 5 | Consumer Discretionary | 10.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LVLT
26
DELISTED
Level 3 Communications Inc
LVLT
| $172M | 0.39% |
3,259,553
-943,800
| -22% | -$51.7M |
|
|
BCR
27
DELISTED
CR Bard Inc.
BCR
| $163M | 0.37% |
957,500
-155,400
| -14% | -$26.6M |
|
28
Costco
COST
$415B
| $157M | 0.36% |
1,160,939
-34,061
| -3% | -$4.9M |
|
29
Southwest Airlines
LUV
$22.1B
| $154M | 0.35% |
4,657,980
+2,146,080
| +85% | +$83.9M |
|
|
30
Gilead Sciences
GILD
$161B
| $153M | 0.35% |
1,310,100
-2,721,948
| -68% | -$297M |
|
31
Duke Energy
DUK
$102B
| $152M | 0.35% |
2,148,367
-21,600
| -1% | -$1.63M |
|
|
B
32
Barrick Mining
B
$62.2B
| $150M | 0.34% |
14,030,102
+673,000
| +5% | +$8.2M |
|
33
Amdocs
DOX
$5.53B
| $147M | 0.34% |
2,700,700
-478,700
| -15% | -$26.3M |
|
34
Sempra
SRE
$60.8B
| $147M | 0.33% |
2,968,800
+926,400
| +45% | +$49M |
|
35
PLDT
PHI
$4.25B
| $143M | 0.33% |
2,298,315
-16,585
| -0.7% | -$1.06M |
|
36
Manhattan Associates
MANH
$8.97B
| $143M | 0.33% |
2,392,900
-158,600
| -6% | -$8.78M |
|
37
United Therapeutics
UTHR
$26.3B
| $141M | 0.32% |
811,578
+365,078
| +82% | +$65.7M |
|
38
Berkshire Hathaway Class B
BRK.B
$1.07T
| $138M | 0.31% |
1,011,500
-374,300
| -27% | -$53.4M |
|
39
GSK
GSK
$103B
| $135M | 0.31% |
2,596,880
+506,800
| +24% | +$28.5M |
|
40
Welltower
WELL
$178B
| $135M | 0.31% |
2,051,763
+619,363
| +43% | +$44.4M |
|
41
Nokia
NOK
$50.8B
| $132M | 0.3% |
19,318,600
+2,897,100
| +18% | +$21.1M |
|
|
CYBX
42
DELISTED
CYBERONICS INC
CYBX
| $131M | 0.3% |
2,203,094
+137,900
| +7% | +$8.68M |
|
|
VGR
43
DELISTED
Vector Group Ltd.
VGR
| $130M | 0.3% |
9,999,838
+402,921
| +4% | +$5.01M |
|
|
44
Verizon
VZ
$194B
| $128M | 0.29% |
+2,755,602
| New | +$135M |
|
45
Cinemark Holdings
CNK
$3.82B
| $126M | 0.29% |
3,133,300
+276,600
| +10% | +$11.5M |
|
|
BT
46
DELISTED
BT Group plc (ADR)
BT
| $124M | 0.28% |
3,499,400
+90,200
| +3% | +$3.15M |
|
|
47
McKesson
MCK
$98.5B
| $123M | 0.28% |
+546,400
| New | +$126M |
|
48
Teva Pharmaceuticals
TEVA
$35.9B
| $123M | 0.28% |
2,075,763
+736,800
| +55% | +$45.5M |
|
49
Clorox
CLX
$11.6B
| $118M | 0.27% |
1,138,700
+225,200
| +25% | +$24.3M |
|
50
Visa
V
$677B
| $117M | 0.27% |
1,748,400
-2,533,500
| -59% | -$172M |
|
Similar funds
Renaissance Technologies's Q2 2015 Portfolio in Review
As of Q2 2015, Renaissance Technologies held 3,611 positions worth $43.9B, down 6.5% from $47B the previous quarter. Its ten largest holdings account for 9.7% of the portfolio.
Renaissance Technologies withdrew a net $2.38B in Q2 2015, closing 415 positions and reducing 921 holdings. Its most notable exit was Meta Platforms (Facebook), an estimated $218M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 13% a quarter earlier, followed by Technology and Industrials.
Against the trend, Renaissance Technologies opened a new position in Microsoft worth $306M.
- Renaissance Technologies's largest Q2 2015 buy was Microsoft: 6,935,684 shares worth $306M.
- Renaissance Technologies added most to Alphabet (Google) Class C in Q2 2015, an estimated $131M increase.
- Renaissance Technologies's biggest Q2 2015 reduction was Amazon, cutting an estimated $449M.
- Renaissance Technologies fully exited Meta Platforms (Facebook) in Q2 2015, selling an estimated $218M.
- Renaissance Technologies's ten largest holdings make up 9.7% of its $43.9B portfolio in Q2 2015.
- Renaissance Technologies opened 478 new positions and closed 415 in Q2 2015.
- Renaissance Technologies's portfolio value fell 6.5% quarter-over-quarter to $43.9B.
Based on Renaissance Technologies's 13F filing for Q2 2015, filed 14 Aug 2015.